Houda Boukhebza
Affiliations: | Universite Lyon 1, Villeurbanne, Auvergne-Rhône-Alpes, France |
Area:
Hepatitis B, Immunotherapy, Adenovirus, Vaccine, VirusGoogle:
"Houda Boukhebza"Parents
Sign in to add mentor| Geneviève Inchauspé | grad student | 2014 | Universite Lyon 1 | |
| (Caractérisation de produits d'immunothérapie ciblant l’infection chronique par le virus de l’hépatite B) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Martin P, Dubois C, Jacquier E, et al. (2014) TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice. Gut |
| Boukhebza H, Dubois C, Koerper V, et al. (2014) Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naïve and tolerant mouse models. Vaccine. 32: 3256-63 |
| Boukhebza H, Dubois C, Schlesinger Y, et al. (2013) 391 PRE-CLINICAL PROOF-OF-CONCEPT STUDIES EXPLORING SCHEDULES OF ADMINISTRATION OF AN ADENOVIRUS- BASED HBV IMMUNOTHERAPEUTIC SHOW WIDE POTENTIAL FOR INDUCTION OF ROBUST AND LONG-LASTING T-CELL RESPONSES Journal of Hepatology. 58: S161 |
| Martin P, Dubois C, Jacquier E, et al. (2013) 130 A MULTIVALENT ADENOVIRUS-BASED IMMUNOTHERAPEUTIC FOR TREATMENT OF CHRONIC HEPATITIS B INDUCES BROAD, ROBUST AND POLYFUNCTIONAL T CELLS IN NAIVE AND HBV TOLERANT MICE Journal of Hepatology. 58: S57-S58 |
| Boukhebza H, Bellon N, Limacher JM, et al. (2012) Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines. Human Vaccines & Immunotherapeutics. 8: 1746-57 |